Status:
UNKNOWN
Nanovectors to Prevent Placental Passage of Tocolytic Agents
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Preterm Labor
Eligibility:
FEMALE
18-49 years
Brief Summary
The purpose of the study is to find out whether indomethacin encapsulated within a nanovector can stop contractions in pregnant human uterine tissue. Preterm delivery is a major contributor to newborn...
Detailed Description
This is a prospective observational study. Subjects will undergo a biopsy from the middle of the upper margin of the uterine incision measuring 4 x 2 x 2 cm. This will be performed by the managing do...
Eligibility Criteria
Inclusion
- Pregnant women undergoing elective cesarean section who are greater than 37 weeks
Exclusion
- Known infection
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02199756
Start Date
July 1 2014
End Date
July 1 2019
Last Update
November 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital Texas Medical Center
Houston, Texas, United States, 77030